• 117 Citations
  • 6 h-Index
20162019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Simonetta Buglioni is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Breast Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Stomach Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Mutation Medicine & Life Sciences
DNA Damage Medicine & Life Sciences
DNA Repair Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2016 2019

  • 117 Citations
  • 6 h-Index
  • 25 Article
  • 1 Comment/debate
  • 1 Review article
1 Citation (Scopus)

HSP90 Inhibition Drives Degradation of FGFR2 Fusion Proteins: Implications for Treatment of Cholangiocarcinoma

Lamberti, D., Cristinziano, G., Porru, M., Leonetti, C., Egan, J. B., Shi, C. X., Buglioni, S., Amoreo, C. A., Castellani, L., Borad, M. J., Alemà, S., Anastasi, S. & Segatto, O., Jan 2019, In : Hepatology. 69, 1, p. 131-142 12 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)

Mutations in the KEAP1-NFE2L2 Pathway Define a Molecular Subset of Rapidly Progressing Lung Adenocarcinoma

Goeman, F., De Nicola, F., Scalera, S., Sperati, F., Gallo, E., Ciuffreda, L., Pallocca, M., Pizzuti, L., Krasniqi, E., Barchiesi, G., Vici, P., Barba, M., Buglioni, S., Casini, B., Visca, P., Pescarmona, E., Mazzotta, M., De Maria, R., Fanciulli, M., Ciliberto, G. & 1 others, Maugeri-Saccà, M., Nov 2019, In : Journal of Thoracic Oncology. 14, 11, p. 1924-1934 11 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and-B breast cancer subtypes

Lattanzio, R., Iezzi, M., Sala, G., Tinari, N., Falasca, M., Alberti, S., Buglioni, S., Mottolese, M., Perracchio, L., Natali, P. G. & Piantelli, M., Jul 30 2019, In : BMC Cancer. 19, 1, 747.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)

Predictive signatures inform the effective repurposing of decitabine to treat KRAS-dependent pancreatic ductal adenocarcinoma

Mottini, C., Tomihara, H., Carrella, D., Lamolinara, A., Iezzi, M., Huang, J. K., Amoreo, C. A., Buglioni, S., Manni, I., Robinson, F. S., Minelli, R., Kang, Y., Fleming, J. B., Kim, M. P., Bristow, C. A., Trisciuoglio, D., Iuliano, A., Bufalo, D. D., Bernardo, D. D., Melisi, D. & 4 others, Draetta, G. F., Ciliberto, G., Carugo, A. & Cardone, L., Nov 1 2019, In : Cancer Research. 79, 21, p. 5612-5625 14 p.

Research output: Contribution to journalArticle

Open Access
1 Citation (Scopus)

Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer

Pallocca, M., Goeman, F., de Nicola, F., Melucci, E., Sperati, F., Terrenato, I., Pizzuti, L., Casini, B., Gallo, E., Amoreo, C. A., Vici, P., di Lauro, L., Buglioni, S., Diodoro, M. G., Pescarmona, E., Mazzotta, M., Barba, M., Fanciulli, M., de Maria, R., Ciliberto, G. & 1 others, Maugeri-Saccà, M., Sep 4 2018, In : Journal of Translational Medicine. 16, 1, p. 247

Research output: Contribution to journalComment/debate

Chemotherapy
Missense Mutation
Stomach Neoplasms
Mutation
Survival